Acasă › Colită ulcerativă › Massachusetts
Studii clinice pentru Colită ulcerativă în Massachusetts
16 studii pentru Colită ulcerativă caută participanți în Massachusetts.
Orașe în Massachusetts
Text oficial al studiului (în engleză)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 29 sept. 2026 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
În curs de recrutareFaza 2/3
Vârste de la 2 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
În curs de recrutareFaza 3
Vârste de la 2 la 19 · Toate sexele · Actualizat 22 sept. 2026 · NCT04844606An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 20 aug. 2026 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 5 aug. 2026 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 21 iul. 2026 · NCT06420375A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
În curs de recrutareFaza 2
Vârste de la 12 la 17 · Toate sexele · Actualizat 8 iul. 2026 · NCT05287126Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
În curs de recrutare
Vârste de la 18 la 85 · Toate sexele · Actualizat 8 ian. 2026 · NCT05987852Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 20 oct. 2025 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
În curs de recrutareStudiu observațional
Vârste de la 5 la 25 · Toate sexele · Actualizat 3 mar. 2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de 14 ani și peste · Toate sexele · Actualizat 20 dec. 2024 · NCT06655415Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.